Загрузка...
Iatrogenic Cushing Syndrome from Interaction Between Ritonavir and Oral Budesonide During Direct Acting Antiviral Hepatitis C Therapy
Direct acting antiviral (DAA) regimens containing ritonavir have been developed to treat hepatitis C, with fewer side effects than that by interferon-based regimens. However prescribers must be aware of drug–drug interactions. There are multiple reports of iatrogenic Cushing syndrome (CS) caused by...
Сохранить в:
| Опубликовано в: : | J Clin Exp Hepatol |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5052398/ https://ncbi.nlm.nih.gov/pubmed/27746623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2016.05.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|